Who
Randall Moreadith
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Serina Therapeutics; Other, Cardium Therapeutics.
In numbers
- Trades disclosed
- 159
- Buys
- 0
- Sells
- 41
- Bought
- $0
- Sold
- $1.3M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 5 Aug 2008
- Last trade
- 21 May 2026
- Last filed
- 26 May 2026
Companies traded
Activity over time
1 Jun 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 May 2026filed 26 May 2026 | SER Serina Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,558 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | SER Serina Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,558 at $0.00 | filing |
| 23 Mar 2026filed 24 Mar 2026 | SER Serina TherapeuticsBiotechnology | SEC FORM 4 Code M | $3906,500 at $0.06 | filing |
| 23 Mar 2026filed 24 Mar 2026 | SER Serina TherapeuticsBiotechnology | SEC FORM 4 Sold | $19K6,500 at $2.86 | filing |
| 23 Mar 2026filed 24 Mar 2026 | SER Serina Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,500 at $0.00 | filing |
| 23 Mar 2026filed 24 Mar 2026 | SER Serina Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,500 at $0.00 | filing |
| 23 Mar 2026filed 24 Mar 2026 | SER Serina TherapeuticsBiotechnology | SEC FORM 4 Code M | $3906,500 at $0.06 | filing |
| 23 Mar 2026filed 24 Mar 2026 | SER Serina TherapeuticsBiotechnology | SEC FORM 4 Sold | $19K6,500 at $2.86 | filing |
| 19 Mar 2026filed 20 Mar 2026 | SER Serina TherapeuticsBiotechnology | SEC FORM 4 Code M | $2,34039,000 at $0.06 | filing |
| 19 Mar 2026filed 20 Mar 2026 | SER Serina TherapeuticsBiotechnology | SEC FORM 4 Sold | $98K39,000 at $2.50 | filing |
| 19 Mar 2026filed 20 Mar 2026 | SER Serina Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —39,000 at $0.00 | filing |
| 19 Mar 2026filed 20 Mar 2026 | SER Serina Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —39,000 at $0.00 | filing |
| 19 Mar 2026filed 20 Mar 2026 | SER Serina TherapeuticsBiotechnology | SEC FORM 4 Code M | $2,34039,000 at $0.06 | filing |
| 19 Mar 2026filed 20 Mar 2026 | SER Serina TherapeuticsBiotechnology | SEC FORM 4 Sold | $98K39,000 at $2.50 | filing |
| 3 Feb 2026filed 17 Feb 2026 | SER Serina Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —69,000 at $0.00 | filing |
| 3 Feb 2026filed 17 Feb 2026 | SER Serina Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —69,000 at $0.00 | filing |
| 2 Feb 2026filed 3 Feb 2026 | SER Serina TherapeuticsBiotechnology | SEC FORM 4 Code M | $3906,500 at $0.06 | filing |
| 2 Feb 2026filed 3 Feb 2026 | SER Serina TherapeuticsBiotechnology | SEC FORM 4 Sold | $20K6,500 at $3.03 | filing |
| 2 Feb 2026filed 3 Feb 2026 | SER Serina Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,500 at $0.00 | filing |
| 2 Feb 2026filed 3 Feb 2026 | SER Serina Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,500 at $0.00 | filing |
News
Serina Therapeutics, Inc. (NYSEAMERICAN:SER) Stock Short Interest Report for SeptemberSER · tickerreport.com · 14 Oct 2026
0 headlines in the last 90 days name Randall Moreadith; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.